AbbVie (ABBV)

SG&A Expense Growth

1.51%

Quarterly · Period ending:

ABBV logo

ABBV SG&A Expense Growth

Latest reported1.51%
ABBV Quarterly SG&A Growth (QoQ) (0.00% → 1.51%)
High-resolution chart · PNG

ABBV sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AbbVie SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
1.5092%
-8.1386%
9.1342%
9.7141%
-1.2147%
-14.5785%
-8.3234%
24.5188%
1.8703%
3.8209%
-5.3084%
3.1824%
7.5354%
-11.0623%
3.4201%
-38.9505%
73.0732%
-4.0798%
5.7412%
-2.5601%
11.33%
-12.0396%
13.5278%
-19.3082%
108.0826%
-13.1215%
17.7429%
0.1814%
-1.5476%
-12.9082%
0.5211%
9.0341%
-1.7309%
-8.2009%
33.9053%
-3.446%
9.9053%
-16.9389%
19.6959%
-5.7981%
8.1919%
-21.9919%
17.8426%
-13.4469%
15.6144%
-55.9114%
109.4671%
10.1519%
8.0597%
-7.4586%
14.8295%
-10.3129%
13.6621%
-12.2917%
29.9868%
-12.9213%
-0.0802%
9.9616%
-55.3683%
144.0784%
-11.6234%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.